This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
Lucy Chard
25 Nov 2025

CPHI Podcast Series: CPHI Frankfurt special – the future of health

Welcome to this special on-site episode of our podcast, recorded live at CPHI Frankfurt 2025. The following episode encapsulates the key themes that were discussed at CPHI Frankfurt this year. 

In this episode, Editor Vivian Xie speaks to Sabine Kapasi, global health strategist, entrepreneur, and CEO of Enira Consulting. 

This year’s gathering brought together thought leaders, innovators, and policymakers to discuss the most pressing issues and transformative trends shaping the future of healthcare. In this episode, we dive into the heart of these discussions, exploring how the pharmaceutical industry is evolving to meet global health priorities and address critical challenges.

A trained gynecologist and IVF specialist, Sabine blends clinical expertise with deep knowledge in data science, AI, fintech, and health governance. She advises the UN Emergency Response Strategy Team and has previously worked with WHO, leading primary care programmes in 27+ countries. A sought-after speaker at the World Economic Forum, HIMSS, and global health summits, Dr. Kapasi is recognised for shaping innovative, scalable solutions for health equity worldwide.

The episode examines the most significant trends driving the industry today, from the rise of personalised medicine and gene therapies to the growing emphasis on sustainability. These trends are not only reshaping the pharmaceutical landscape but also aligning with global health priorities, such as equitable access to healthcare and the fight against non-communicable diseases.

Emerging markets are playing an increasingly pivotal role in this transformation. Sabine shares her insights on how the European Union is engaging with these regions and the role of the United Nations in fostering collaboration to ensure equitable access to healthcare. We discuss the strategies being implemented to address global disparities in access to essential medicines, particularly in underserved regions, and the importance of partnerships in achieving these goals.

The conversation also highlights the groundbreaking potential of new treatments, including personalised medicine, gene therapies, and biologics, and explores how we can ensure these innovations reach the populations that need them most. Additionally, we delve into the transformative role of technology, particularly data and AI, in improving global health outcomes.

Finally, we tackle the critical issue of sustainability. As the pharmaceutical industry shifts towards more sustainable practices, we see how this transition will shape future trends, business operations, and the creation of a more resilient and inclusive healthcare ecosystem.

Listen now to the episode as we explore the future of global healthcare from the heart of CPHI Frankfurt 2025.

Lucy Chard
Digital Editor - Pharma

Related News